Trending...
- Sober.Buzz the Sober Token : Ticker $BUZZ
- DuoKey to Unveil Encrypted Financial Intelligence Use Case at GISEC Global 2025
- myb.day Launches New Birthday Gift Shop Filled With Personalized Surprises
Join the Honorable Kathleen M. O'Malley (Ret.), Neema Kumar, and Serena Farquharson Torres.
NEW YORK - ncarol.com -- American Conference Institute (ACI) is pleased to announce that the Honorable Kathleen M. O'Malley (Ret.) from Irell & Manella LLP, Neema Kumar from Sandoz, and Serena Farquharson Torres from Bristol Myers Squibb will be chairing the 18th Annual Paragraph IV Disputes conference taking place live and in-person April 19-20, 2023, in New York City.
The Honorable Kathleen M. O'Malley (Ret.) comments, "This year's Paragraph IV Disputes conference comes at an important time. Our innovation and IP Ecosystem are under attack from a variety of sources, putting our economy, the future of our health care, and our strategic place in the world at risk. I look forward to discussing these risks and possible ways to minimize those risks with the talented pool of IP professionals the conference annually brings together. I am also personally pleased that I am being given the chance to conduct a dialogue with Judge Leonard Stark, my successor on the Federal Circuit. That will be a highlight of the Conference for me."
More on ncarol.com
Neema Kumar notes that, "A robust and predictable patent system is critical to incentivizing innovation while facilitating access and ensuring the long-term sustainability of lower cost critical medicines. Join industry leaders, members of the judiciary, key agency representatives and your colleagues as we discuss game changing legislation impacting our industry and patients, current Hatch-Waxman trends, pharmaceutical policy initiatives and much more."
Serena Farquharson Torres adds, "Being on the forefront of pioneering research makes me both excited and hopeful for our patients yet somehow uncertain of the future protection of such innovation. I'm looking forward to hearing from government agencies, the judiciary, in-house and outside counsel regarding various considerations impacting the future of patent procurement as well as patent enforcement."
Leaders from both brand and generic drug companies recognize that this event serves both sides of the industry and offers both legal and economic "take aways" for every sphere of this costly, complex and evolving litigation.
Full information on the event, visit: http://bit.ly/3SDeANQ
# # #
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.
The Honorable Kathleen M. O'Malley (Ret.) comments, "This year's Paragraph IV Disputes conference comes at an important time. Our innovation and IP Ecosystem are under attack from a variety of sources, putting our economy, the future of our health care, and our strategic place in the world at risk. I look forward to discussing these risks and possible ways to minimize those risks with the talented pool of IP professionals the conference annually brings together. I am also personally pleased that I am being given the chance to conduct a dialogue with Judge Leonard Stark, my successor on the Federal Circuit. That will be a highlight of the Conference for me."
More on ncarol.com
- Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
- Cybersecurity is Protecting Your Personal Information and Your Portfolio
- Matthew Glova, CFP® of LifeTime Asset Honored in Forbes Best-In-State Wealth Advisors2025
- L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
- Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
Neema Kumar notes that, "A robust and predictable patent system is critical to incentivizing innovation while facilitating access and ensuring the long-term sustainability of lower cost critical medicines. Join industry leaders, members of the judiciary, key agency representatives and your colleagues as we discuss game changing legislation impacting our industry and patients, current Hatch-Waxman trends, pharmaceutical policy initiatives and much more."
Serena Farquharson Torres adds, "Being on the forefront of pioneering research makes me both excited and hopeful for our patients yet somehow uncertain of the future protection of such innovation. I'm looking forward to hearing from government agencies, the judiciary, in-house and outside counsel regarding various considerations impacting the future of patent procurement as well as patent enforcement."
Leaders from both brand and generic drug companies recognize that this event serves both sides of the industry and offers both legal and economic "take aways" for every sphere of this costly, complex and evolving litigation.
Full information on the event, visit: http://bit.ly/3SDeANQ
# # #
A unique organization, American Conference Institute is devoted to providing the business intelligence that senior decision-makers need to respond to challenges both here in the US, and around the world.
Source: American Conference Institute
0 Comments
Latest on ncarol.com
- The Tide Project Opens at Biennale Architettura 2025 in Venice Amplifying Youth Voices
- Wall Street analysts say BTC.XRP.DOGE cloud mining company SIX MINING is expected to achieve a 5-fold increase, allowing users to easily mine BTC
- Gen X Takes The Reins: New Book Guides Caregivers Juggling Parents, Kids, And Grandkids With Humor And Heart
- Fray Fitness Launches Memorial Day Sale and Veteran Organization Giveaway
- ABM for Good™ Launches First Project with Build Change
- ImagineX, in Collaboration with Qualys, Launches New mROC Services to Transform Enterprise Cyber Risk Management
- Ditch Micromanagement: New Leadership Book for Results-Driven, Accountability-Based Teams
- Jay Tapp was named Managing Director in British Columbia
- Hubei Heavy Equipment Makes a Striking Appearance at CIMT and Competes with International Brands
- 20 Patents Issued Worldwide, Cementing Company Leadership. First Ever Cable-Free 12-Lead ECG: HeartBeam, Inc. (Stock Symbol: BEAT)
- NASDAQ Uplisting for Higher Market Exposure and Wide Corporate Benefits to AI Boosted Marketing Company On Track Towards $1 Billion Revenue by 2027
- Congressional Men's Health Caucus Shows Bipartisan Consensus and Focus on Prevention, Mental Health, and Closing the Lifespan Gap
- DuoKey, Axiomtek and Blue Edge Network Partner to Enhance Smart Cities with Privacy-Preserving Urban Safeguarding and Fleet Management
- Costa Oil Racing and Rick Ware Racing Celebrate Back-to-Back Victories Across the Country
- Austin Keen Joins WakeFX RopePal as Official Brand Ambassador
- Bonelli Systems Expands Managed IT Services Nationwide, Leveraging Microsoft Azure Expertise
- $4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Whistleblower Claims Dental Patient Deaths Likely Due to Book Ban
- Dr. Michael Matzinger Honored with Silver Antelope Award for Distinguished Service to Youth
- xREnergy up as much as +3,094,634% on first day listed on the XRP Ledger. Ticker : $XRE